Marker Therapeutics, Inc.
MRKR
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$1.31
FAIR PRICE
$1.97
MARGIN
$0.66
P/E Ratio
N/A
Div. Yield
N/A
ROE
-92.4%
Market Cap
$14M
Small-cap
COMING SOON
Get notified when MRKR's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Juan F. Vera
COUNTRY
US
HEADQUARTERS
Houston
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate MRKR's fair price
Marker Therapeutics, Inc.'s fair price of $1.97 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%). At the current market price of $1.31, MRKR trades 50.4% below its calculated fair value.
DCF MODEL · 50%
Discounted cash flow analysis based on projected free cash flows, discounted at a rate reflecting MRKR's risk profile.
RELATIVE · 30%
Comparing MRKR's valuation multiples against Healthcare peers.
ANALYST · 20%
Aggregated analyst price targets for MRKR, weighted by recency and analyst accuracy.
POWERED BY BULIOS
Get full analysis, financials, and AI insights for MRKR.
Explore on BuliosFAQ
What is the fair price of MRKR?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Marker Therapeutics, Inc. is $1.97. At the current market price of $1.31, MRKR trades 50.4% below its calculated fair value.
Is MRKR overvalued or undervalued?+
Marker Therapeutics, Inc. is currently undervalued based on our valuation model. The stock trades at $1.31, which is 50.4% below the fair price of $1.97.
How often is MRKR's fair price updated?+
We update fair price calculations for MRKR daily after market close. The current fair price of $1.97 incorporates the latest market data and sector multiples.
What factors affect MRKR's fair price calculation?+
MRKR's fair price of $1.97 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -92.4%.
Is MRKR a good buy right now?+
At $1.31, MRKR trades 50.4% below our fair value estimate of $1.97. The stock is currently undervalued. ROE stands at -92.4% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does MRKR pay dividends?+
MRKR does not currently pay a dividend.